SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-18-001450
Filing Date
2018-02-05
Accepted
2018-02-05 09:11:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 158715
2 ex1.htm EX-1 5810
  Complete submission text file 0001493152-18-001450.txt   166194
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82442 | Film No.: 18572922
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G